Jong‐Mu Sun

12.7k citations
222 papers · 9.6k · 4 hit papers · h-index 51

Impact in

  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Lung Cancer Treatments and Mutations 94
    • Lung Cancer Diagnosis and Treatment 17
    • Gastric Cancer Management and Outcomes 13
    • Cancer Immunotherapy and Biomarkers 29
    • Colorectal Cancer Treatments and Studies 18
    • Lung Cancer Research Studies 17

Jong‐Mu Sun

220 papers receiving 9.4k citations

Jong‐Mu Sun's Hit Papers

Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma 2020 · 866 citations
8660+5+10Years since publication250500750

Peers

Jong‐Mu Sun
Comparison fields: 5 of 126
  • Oncology 4.3k
  • Pulmonary and Respiratory Medicine 4.7k
  • Cancer Research 1.2k
  • Otorhinolaryngology 213
  • Immunology 773
Replace Thomas Christoph Gauler with:
Thomas Christoph Gauler Germany
Emmanuelle Bompas France
Zsuzsanna Pápai Hungary
Sérgio Jobim Azevedo Brazil
Stephen Broderick United States
Maurice Pérol France
Jin‐Haeng Chung South Korea
Gyula Ostoros Hungary
Juan José Zarbá Argentina
Erminia Massarelli United States
Jong‐Mu Sun relative to Thomas Christoph Gauler Germany Thomas Christoph Gauler's profile →
Citations per field
00.5×1.5×2×2.4×
Thomas Christoph Gauler · 1×
Citations per year

Countries citing papers authored by Jong‐Mu Sun

Since Specialization
Citations

This map shows the geographic impact of Jong‐Mu Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jong‐Mu Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jong‐Mu Sun more than expected).

Fields of papers citing papers by Jong‐Mu Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jong‐Mu Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jong‐Mu Sun. The network helps show where Jong‐Mu Sun may publish in the future.

Co-authors

The 25 scholars most cited alongside Jong‐Mu Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jong‐Mu Sun Line = papers co-authored together Jong‐Mu Sun links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 222 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma
Hit paper breakdown →
2020866
2
Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study
Hit paper breakdown →
2011391
3
Osimertinib for Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)
Hit paper breakdown →
2019299
4
Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial
Hit paper breakdown →
2018261
5 2015211
6 2017210
7 2016200
8 2013174
9 2019168
10 2016165
11 2013155
12 2017150
13 2019150
14 2019147
15 2020146
16 2012137
17 2018130
18 2019124
19 2015122
20 2020116

About Jong‐Mu Sun

Jong‐Mu Sun is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Otorhinolaryngology and Cancer Research, having authored 222 papers that have together received 9.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (94 papers), Cancer Immunotherapy and Biomarkers (29 papers), Colorectal Cancer Treatments and Studies (18 papers), Lung Cancer Research Studies (17 papers), Lung Cancer Diagnosis and Treatment (17 papers), Esophageal Cancer Research and Treatment (16 papers), Gastric Cancer Management and Outcomes (13 papers) and Cancer Genomics and Diagnostics (10 papers). The work is most often cited by research in Oncology (4.3k citations), Pulmonary and Respiratory Medicine (4.7k citations), Cancer Research (1.2k citations), Otorhinolaryngology (213 citations) and Immunology (773 citations). Jong‐Mu Sun has collaborated with scholars based in South Korea, United States and China. Frequent co-authors include Myung‐Ju Ahn, Keunchil Park, Jin Seok Ahn, Se‐Hoon Lee, Yoon‐La Choi, Bo Mi Ku, Joungho Han, Hyun Ae Jung, Sung Hee Lim and Myung‐Ju Ahn. Their work appears in journals such as Journal of Thoracic Oncology, Lung Cancer, Cancer Research and Treatment, Annals of Oncology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact